Related Experiment Video
Updated: Aug 15, 2026
09:42
Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
Published on: November 9, 2013
Treatment adherence improves outcomes and manages costs
1University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
The AIDS Reader
|March 31, 2001
Summary
Achieving high adherence (95%+) to highly active antiretroviral therapy (HAART) is crucial for HIV treatment success. Strategies addressing patients, providers, and regimens, like dedicated treatment adherence committees (TACs), are vital for improving outcomes.
Area of Science:
- Infectious Diseases
- Pharmacology
- Public Health
Background:
- Chronic disease treatment adherence averages 50%, but HIV requires 95%+ adherence for optimal outcomes.
- Highly active antiretroviral therapy (HAART) is effective and cost-effective, reducing hospitalizations and improving quality of life.
- Real-world adherence to antiretroviral treatment (ART) often falls short of clinical trial performance, necessitating adherence strategies.
Purpose of the Study:
- To highlight the critical need for high adherence in HIV treatment with HAART.
- To explore strategies for improving patient adherence to complex antiretroviral regimens.
- To evaluate the cost-effectiveness of interventions like treatment adherence committees (TACs) in managed care.
Main Methods:
- Review of existing literature on chronic disease and HIV treatment adherence.
- Analysis of cost-effectiveness data for HAART, including drug costs versus healthcare utilization savings.
- Discussion of multidisciplinary approaches to enhance patient adherence to antiretroviral therapy.
Main Results:
- HAART significantly improves outcomes and quality of life, with cost savings from reduced hospitalizations.
- High adherence (95%+) is essential for HAART efficacy and preventing antiretroviral resistance.
- Dedicated TACs show promise as effective components of adherence strategies in managed care settings.
Conclusions:
- Improving adherence to HAART is paramount for successful long-term HIV management.
- Multifaceted strategies targeting patients, providers, and treatment regimens are necessary.
- TACs represent a potentially cost-effective addition to managed care for enhancing HIV treatment adherence.
Related Concept Videos
01:13Patient-centered Care
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
01:15Methods of Documentation VI: Case Management Model
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
For example, a patient with a chronic illness...
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications